Legend Biotech Corp (LEGN)
45.26
-0.15
(-0.33%)
USD |
NASDAQ |
May 06, 16:00
45.25
-0.01
(-0.02%)
After-Hours: 20:00
Legend Biotech Gross Profit Margin (Quarterly): 59.16% for Dec. 31, 2023
Gross Profit Margin (Quarterly) Chart
Historical Gross Profit Margin (Quarterly) Data
Date | Value |
---|---|
December 31, 2023 | 59.16% |
September 30, 2023 | 54.72% |
June 30, 2023 | 55.45% |
March 31, 2023 | 1.99% |
Date | Value |
---|---|
December 31, 2022 | 16.90% |
September 30, 2022 | 6.95% |
June 30, 2022 | -41.50% |
Gross Profit Margin Definition
Gross Profit Margin is calculated using Gross Profit/Revenue. This metric measures the overall efficiency of a company in being able to turn revenue into gross profit and doing this by keeping cost of goods sold low. An analyst looking at gross profit margin might look for a higher gross profit margin relative to other comparable companies as well as a gross profit margin that is growing.
Gross Profit Margin (Quarterly) Range, Past 5 Years
-41.50%
Minimum
Jun 2022
59.16%
Maximum
Dec 2023
21.95%
Average
16.90%
Median
Dec 2022
Gross Profit Margin (Quarterly) Benchmarks
Johnson & Johnson | 69.55% |
Bristol-Myers Squibb Co | 75.29% |
2seventy bio Inc | 70.54% |
Exelixis Inc | 95.00% |
Alnylam Pharmaceuticals Inc | 86.65% |
Gross Profit Margin (Quarterly) Related Metrics
Return on Equity | -48.03% |
Return on Assets | -31.76% |
Return on Invested Capital | -38.39% |
Profit Margin (Quarterly) | -182.2% |
Operating Margin (Quarterly) | -150.8% |
Return on Net Operating Assets | -129.1% |